Da-Bu-Yin-Wan rescues cognitive deficits in aging and Alzheimer's disease models by Wnt/β-catenin-dependent restoration of lysosomal acidification.
Abstract
Lysosomal acidification deficits are increasingly recognized as a convergent pathological mechanism driving both age-related cognitive decline (ARCD) and early Alzheimer's disease (AD) progression, creating a self-reinforcing cycle of cellular aging and Aβ dyshomeostasis. Despite demonstrated neuroprotective effects of Da-Bu-Yin-Wan (DBYW) in Parkinson's disease models, its therapeutic potential for lysosomal dysfunction in ARCD and AD remains an uncharted area of investigation.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Da-Bu-Yin-Wan improves cognitive deficits in aging and Alzheimer's disease models by restoring lysosomal acidification through Wnt/β-catenin signaling. The paper addresses a potential therapeutic approach to a root cause of cognitive decline associated with aging and Alzheimer's disease, focusing on lysosomal dysfunction, which is relevant to longevity research.
Author of this paper? Send a correction.